Johnson & Johnson (JNJ) Institutional Ownership
13F filers reported holding 76.3% of Johnson & Johnson (JNJ) shares as of Jun 30, 2026, across 4,741 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 76.3%
- Jun 30, 2026
- 13F filers
- 4,741
- quarter ended Jun 30, 2026
- 13F value
- $466.6B
- 1.8B shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Pinto Daniel E | director | Acquired · Grant / award | 113Deferred Share Units | $276.31 | ↗ |
| Sep 8, 2026 | Woods Eugene A. | director | Acquired · Grant / award | 136Deferred Share Units | $276.31 | ↗ |
| Sep 8, 2026 | HEWSON MARILLYN A | director | Acquired · Grant / award | 181Deferred Share Units | $276.31 | ↗ |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Acquired · Option exercise | 11,070 | $131.94 | ↗ |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Disposed · Open-market sale | 11,070 | $274.74 | ↗ |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Acquired · Option exercise | 22,527 | $151.41 | ↗ |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Disposed · Open-market sale | 22,527 | $274.74 | ↗ |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Disposed · Option exercise | 11,070Employee Stock Options (Right to Buy) | — | ↗ |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | Disposed · Option exercise | 22,527Employee Stock Options (Right to Buy) | — | ↗ |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Acquired · Option exercise | 15,000 | $115.67 | ↗ |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Disposed · Open-market sale | 15,000 | $263.36 | ↗ |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Disposed · Option exercise | 15,000Employee Stock Options (Right to Buy) | — | ↗ |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Acquired · Option exercise | 123,291 | $115.67 | ↗ |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Disposed · Open-market sale | 20,976 | $262.00 | ↗ |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Disposed · Open-market sale | 102,315 | $261.00 | ↗ |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | Disposed · Option exercise | 123,291Employee Stock Options (Right to Buy) | — | ↗ |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Acquired · Option exercise | 9,344 | $131.94 | ↗ |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Disposed · Open-market sale | 9,344 | $257.76 | ↗ |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Disposed · Open-market sale | 6,574 | $255.93 | ↗ |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | Disposed · Option exercise | 9,344Employee Stock Options (Right to Buy) | — | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Johnson & Johnson do institutions hold?
13F filers reported holding 76.3% of Johnson & Johnson's shares as of Jun 30, 2026, across 4,741 filers.
How many 13F filers hold Johnson & Johnson?
Johnson & Johnson was held by 4,741 13F filers as of Jun 30, 2026.
Not investment advice.

